SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001860782-23-000126
Filing Date
2023-12-01
Accepted
2023-12-01 06:43:57
Documents
14
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A tsvt-20230331.htm   iXBRL 10-Q/A 37522
2 EX-31.1 tsvt-q1202310xqexhibit311.htm EX-31.1 8880
3 EX-31.2 tsvt-q1202310xqexhibit312.htm EX-31.2 8879
  Complete submission text file 0001860782-23-000126.txt   223603

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tsvt-20230331.xsd EX-101.SCH 1926
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tsvt-20230331_lab.xml EX-101.LAB 31864
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tsvt-20230331_pre.xml EX-101.PRE 16826
8 EXTRACTED XBRL INSTANCE DOCUMENT tsvt-20230331_htm.xml XML 3838
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40791 | Film No.: 231457495
SIC: 2834 Pharmaceutical Preparations